Back to top
more

Henry Schein (HSIC)

(Real Time Quote from BATS)

$71.07 USD

71.07
351,499

-0.87 (-1.21%)

Updated Oct 2, 2024 12:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (170 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Henry Schein (HSIC) to Report Q4 Earnings: What's in Store?

Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q4.

The Zacks Analyst Blog Highlights: ResMed, Invacare, Fresenius, Henry Schein and Quest Diagnostics

The Zacks Analyst Blog Highlights: ResMed, Invacare, Fresenius, Henry Schein and Quest Diagnostics

Debanjana Dey headshot

4 MedTech Underperformers Poised for a Turnaround in 2021

Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.

Henry Schein (HSIC) Grows Inorganically, Closes JV, Buys Stake

The developments are expected to strengthen Henry Schein's (HSIC) presence in high potential and still-untapped markets.

Can Value Investors Henry Schein (HSIC) Stock Right Now?

Is Henry Schein (HSIC) a great pick from the value investor's perspective right now? Read on to know more.

Henry Schein (HSIC) Up 7.5% Since Last Earnings Report: Can It Continue?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Henry Schein (HSIC) Q3 Earnings Top Estimates, Margins Dip

Henry Schein (HSIC) sees robust segmental performance in Q3 boosted by strong rebound in sales and solid demand for PPE and COVID-19-related products.

Henry Schein (HSIC) Tops Q3 Earnings and Revenue Estimates

Henry Schein (HSIC) delivered earnings and revenue surprises of 43.06% and 16.55%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Products Earnings Due on Nov 2: STE, HSIC & More

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

Why Henry Schein (HSIC) Might Surprise This Earnings Season

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Trina Mukherjee headshot

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.

Henry Schein (HSIC) to Report Q3 Earnings: What's in Store?

Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q3.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Should You Buy?

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Align (ALGN) Unveils New Product for Better Treatment Option

Align Technology's (ALGN) latest product to aid in improving doctor performance and ensure better treatment planning.

Henry Schein Partners MouthWatch to Grow in Teledentistry

Henry Schien's (HSIC) customer base is likely to benefit from the Teledent platform.

Henry Schein (HSIC) Enters Into New Dental Deal With Zyris

Henry Schien (HSIC) is set to be the exclusive distributor of Zyris products like Isolite 3, Isovac 2, Isodry and the company's patented single-use Mouthpieces.

Henry Schein (HSIC) Down 0.4% Since Last Earnings Report: Can It Rebound?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Henry Schein (HSIC) Q2 Earnings Top Estimates, Margins Dip

Henry Schein (HSIC) sees dismal segmental performance in Q2 due to disruptions resulting from the coronavirus pandemic.

Henry Schein (HSIC) Reports Break-Even Earnings for Q2

Henry Schein (HSIC) delivered earnings and revenue surprises of 100.00% and 19.98%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Henry Schein (HSIC)

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

Henry Schein's (HSIC) medical business' PPE sales are likely to have boosted Q2 performance amid the coronavirus pandemic.

Why the Earnings Surprise Streak Could Continue for Henry Schein (HSIC)

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Henry Schein Banks on Dental Consumable Amid Coronavirus Woes

Henry Schein (HSIC) seems upbeat about its dental technology business, Henry Schein One.

Henry Schein Medical to Expand in Telemedicine With VisualDx

Henry Schein's (HSIC) VisualDx system to be integrated with Medpod's technology infrastructure for improved patient outcome.